News

Published on 21 Nov 2024 on Barrons.com

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop


Article preview image

Kennedy isn’t a fan of Novo Nordisk’s weight-loss treatment Ozempic, which costs the government too...

NYSE.NVO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk...

In a recent interview with Fox News, RFK Jr...rather than pharmaceuticals. He also called out...

Investor's Business Daily 22 Nov 2024

PFE vs. NVO: Which Stock Is the Better Value Option?

This means that PFE's earnings estimate revision activity has been more impressive, so investors ...

Zacks · via Yahoo Finance 21 Nov 2024

Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop

Kennedy isn’t a fan of Novo Nordisk’s weight-loss treatment Ozempic, which costs the government t...

Barrons.com 21 Nov 2024

3 Growth Stocks You Can Buy Right Now Without Any Hesitation | The Motley Fool

Here's why they view Eli Lilly (LLY -1.80%), Novo Nordisk (NVO -3.04%), and Vertex Pharmaceutical...

The Motley Fool 18 Nov 2024

A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new...

Ozempic works by mimicking a hormone that regulates blood sugar and suppresses appetite. In...

Quartz 18 Nov 2024

Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk

↘️ Applied Materials (AMAT): Shares fell 8% after the semiconductor-equipment company posted a...

The Wall Street Journal 15 Nov 2024

Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter

Polen Capital, an investment management company, released its “Polen Global Growth Strategy”...

Insider Monkey · via Yahoo Finance 15 Nov 2024

Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc

The stock's average trading price was $1,112.86 during the quarter, with a -30.47% return over th...

GuruFocus.com · via Yahoo Finance 14 Nov 2024

Novo Nordisk's SWOT analysis: obesity drug leader faces fierce competition By...

Novo Nordisk A/S (NYSE:NVO), a global healthcare company specializing in diabetes care and obesit...

Investing.com 13 Nov 2024

Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Ma...

Insider Monkey · via Yahoo Finance 12 Nov 2024